Community Research and Development Information Service - CORDIS

Control of lung infection, allergy and inflammation: assessment of the therapeutic potential of recombinant forms of lung surfactant proteins sp-a and sp-d.

From 2000-09-01 to 2003-11-30

Project details

Total cost:

EUR 1 867 273

EU contribution:

EUR 1 299 957

Coordinated in:

United Kingdom

Funding scheme:

CSC - Cost-sharing contracts

Objective

Coordinator

Medical Research Council (MRC)
United Kingdom
20 Park Crescent
W1N 4AL London
United Kingdom
See on map
Administrative contact: Anne-Marie CORIAT

Participants

ALTANA PHARMA A.G.
Germany
Byk-Gulden Str. 2
78467 KONSTANZ
Germany
See on map
Administrative contact: Heinz RADTKE
UNIVERSIDAD COMPLUTENSE DE MADRID
Spain
Ciudad Universitaria s/n
28040 MADRID
Spain
See on map
Administrative contact: Agustin ZAPATA-GONZALEZ
UNIVERSITY OF SOUTHERN DENMARK - UNIVERSITY OF ODENSE
Denmark
Winsloeevparken 21
5000 ODENSE
Denmark
Administrative contact: Vagn HOLMEGAARD
UTRECHT UNIVERSITY
Netherlands
Yalelaan 1
3584 CL UTRECHT
Netherlands
See on map
Administrative contact: G.A. CORNELISSEN
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top